Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

17b-Estradiol in skin affects hair growth and tumor promotion.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Human sebaceous glands can grow normally for a week without certain growth factors, and adding estrogen reduces their oil production without affecting cell growth.

Ethosomal gels improve drug delivery through the skin, enhancing treatment effectiveness.

Ethosomal gels improve drug delivery through the skin, enhancing treatment effectiveness.

The effects of estrogen on human hair growth are unclear and need more research.

A woman's excessive hair growth around a leg ulcer was linked to a treatment with Prostaglandin E1 ointment.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

The treatment slightly increased hair growth and was safe for most women.

Hair lotions with 17 alpha-estradiol can reduce hair loss but won't regrow new hair.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.